US Stock MarketDetailed Quotes
ASLN Aslan Pharmaceuticals
- 1.3380
- -0.0420-3.04%
Trading Jul 16 09:38 ET
3.78MMarket Cap-86P/E (TTM)
1.3474High1.2700Low115.77KVolume1.3300Open1.3800Pre Close151.77KTurnover4.66%Turnover RatioLossP/E (Static)2.83MShares22.160052wk High-0.21P/B3.33MFloat Cap1.270052wk Low--Dividend TTM2.49MShs Float417.5600Historical High--Div YieldTTM5.61%Amplitude1.2700Historical Low1.3110Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Aslan Pharmaceuticals Stock Forum
5 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company dedicated to developing innovative treatments for patients, has announced a significant late-breaking poster presentation at the American Thoracic Society (ATS) International Conference 2024 in San Diego, Californ...
•Late breaking poster presentation of positive translational data from a head-to-head study of eblasakimab versus dupilumab in a human tissue model of COPD at the American Thoracic Society International Conference 2024 on May 20, 2024 •Topline interim data from the farudodstat Phase 2a study in AA expected in Q3 2024•Topline data from the TREK-DX trial of eblasakimab expected at the end of 2024•Selection of a dev...
Hi @Trytosaveabit May i kindly get ur opinion/ analysis on this company (No advise on buy sell).
No comment yet